These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Effect of glucose in dialysis fluid on antibacterial defence in the peritoneal cavity. Calame W; Hendrickx RJ; Namavar F; Oe LP; Beelen RH J Infect; 1995 May; 30(3):227-33. PubMed ID: 7673747 [TBL] [Abstract][Full Text] [Related]
28. Serial changes of interleukin-6 and interleukin-8 levels in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis. Lin CY; Lin CC; Huang TP Nephron; 1993; 63(4):404-8. PubMed ID: 8459875 [TBL] [Abstract][Full Text] [Related]
29. Rapid detection of causative pathogen of peritonitis using in-situ hybridization in a patient with continuous ambulatory peritoneal dialysis. Ota K; Maruyama H; Iino N; Nakamura G; Shimotori M; Tanabe Y; Tsukada H; Gejyo F J Infect Chemother; 2007 Aug; 13(4):273-5. PubMed ID: 17721693 [TBL] [Abstract][Full Text] [Related]
30. Interleukin-6 and interleukin-8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Brauner A; Hylander B; Wretlind B Am J Kidney Dis; 1993 Sep; 22(3):430-5. PubMed ID: 8372840 [TBL] [Abstract][Full Text] [Related]
31. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Brauner A; Hylander B; Wretlind B Am J Kidney Dis; 1996 Mar; 27(3):402-8. PubMed ID: 8604710 [TBL] [Abstract][Full Text] [Related]
32. Generalized lymphadenopathy in continuous ambulatory peritoneal dialysis patients associated with Staphylococcus epidermidis infection. Pollock CA; Ibels LS Nephron; 1989; 52(1):81-2. PubMed ID: 2710271 [TBL] [Abstract][Full Text] [Related]
33. Cell populations present in the nocturnal peritoneal effluent of patients on continuous ambulatory peritoneal dialysis and their relationship with peritoneal function and incidence of peritonitis. Fernandez de Castro M; Selgas R; Jimenez C; Auxiliadora Bajo M; Martinez V; Romero JR; de Alvaro F; Vara F Perit Dial Int; 1994; 14(3):265-70. PubMed ID: 7948240 [TBL] [Abstract][Full Text] [Related]
35. Response of chronic renal failure mice to peritoneal Staphylococcus epidermidis challenge: impact of repeated peritoneal instillation of dialysis solution. Gallimore B; Gagnon RF; Richards GK Am J Kidney Dis; 1989 Sep; 14(3):184-95. PubMed ID: 2773921 [TBL] [Abstract][Full Text] [Related]
36. CAPD peritonitis induces the production of a novel peptide, daintain/allograft inflammatory factor-1. Brauner A; Hertting O; Alkstrand E; Sandberg E; Chromek M; Chen ZW; Ostenson CG Perit Dial Int; 2003; 23(1):5-13. PubMed ID: 12691501 [TBL] [Abstract][Full Text] [Related]
37. [Clinical analysis for patients with continuous ambulatory peritoneal dialysis associated peritonitis]. Liu J; Huang X; Liu Y; Xu H; Gong R; Li C Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 41(12):1328-1333. PubMed ID: 28070047 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and ex vivo susceptibility of cefpodoxime proxetil in patients receiving continuous ambulatory peritoneal dialysis. Johnson CA; Ateshkadi A; Zimmerman SW; Hughes GS; Craig WA; Carey PM; Borin MT Antimicrob Agents Chemother; 1993 Dec; 37(12):2650-5. PubMed ID: 8109931 [TBL] [Abstract][Full Text] [Related]
39. Effect of glucose concentration and dwell time of dialysis fluid on the antibacterial defense in the peritoneal cavity of rats. Calame W; Hendrickx RJ; Oe LP; Namavar F; Beelen RH Adv Perit Dial; 1992; 8():219-22. PubMed ID: 1361790 [TBL] [Abstract][Full Text] [Related]
40. Establishing an experimental infection model for peritoneal dialysis: effect of inoculum and volume. Calame W; Afram C; Blijleven N; Hendrickx RJ; Namavar F; Beelen RH Perit Dial Int; 1993; 13 Suppl 2():S79-80. PubMed ID: 8399677 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]